<VariationArchive VariationID="2055376" VariationName="NM_145239.3(PRRT2):c.1007del (p.Asn335_Leu336insTer)" VariationType="Deletion" Accession="VCV002055376" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2105493" VariationID="2055376">
      <GeneList>
        <Gene Symbol="MVP-DT" FullName="MVP divergent transcript" GeneID="112268170" HGNC_ID="HGNC:56029" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>16p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="29808644" stop="29820367" display_start="29808644" display_stop="29820367" Strand="-" />
          </Location>
        </Gene>
        <Gene Symbol="PRRT2" FullName="proline rich transmembrane protein 2" GeneID="112476" HGNC_ID="HGNC:30500" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>16p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="29812193" stop="29815881" display_start="29812193" display_stop="29815881" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="29823408" stop="29827201" display_start="29823408" display_stop="29827201" Strand="+" />
          </Location>
          <OMIM>614386</OMIM>
          <Haploinsufficiency last_evaluated="2021-12-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PRRT2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-12-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PRRT2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_145239.3(PRRT2):c.1007del (p.Asn335_Leu336insTer)</Name>
      <CanonicalSPDI>NC_000016.10:29814458:TT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16p11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="29814459" stop="29814459" display_start="29814459" display_stop="29814459" variantLength="1" positionVCF="29814458" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="29825780" stop="29825780" display_start="29825780" display_stop="29825780" variantLength="1" positionVCF="29825779" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.29814460del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.29814460del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.29825781del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.29825781del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_032039.1" sequenceAccession="NG_032039" sequenceVersion="1" change="g.7373del">
            <Expression>NG_032039.1:g.7373del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_032039.2" sequenceAccession="NG_032039" sequenceVersion="2" change="g.7269del">
            <Expression>NG_032039.2:g.7269del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256442.2" sequenceAccession="NM_001256442" sequenceVersion="2" change="c.1007del">
            <Expression>NM_001256442.2:c.1007del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001243371.1" sequenceAccession="NP_001243371" sequenceVersion="1" change="p.Asn335_Leu336insTer">
            <Expression>NP_001243371.1:p.Asn335_Leu336insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256443.2" sequenceAccession="NM_001256443" sequenceVersion="2" change="c.*506del">
            <Expression>NM_001256443.2:c.*506del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_145239.3" sequenceAccession="NM_145239" sequenceVersion="3" change="c.1007del" MANESelect="true">
            <Expression>NM_145239.3:c.1007del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_660282.2" sequenceAccession="NP_660282" sequenceVersion="2" change="p.Asn335_Leu336insTer">
            <Expression>NP_660282.2:p.Asn335_Leu336insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_145239.3(PRRT2):c.1007del (p.Asn335_Leu336insTer) AND Episodic kinesigenic dyskinesia" Accession="RCV002933300" Version="2">
        <ClassifiedConditionList TraitSetID="44946">
          <ClassifiedCondition DB="MedGen" ID="C1868682">Episodic kinesigenic dyskinesia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-03-03" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="44946" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36813" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Familial paroxysmal dystonia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Episodic kinesigenic dyskinesia</ElementValue>
                <XRef ID="MONDO:0044202" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS128200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Paroxysmal kinesigenic dyskinesia</ElementValue>
                <XRef ID="98809" DB="Orphanet" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EKD</ElementValue>
                <XRef ID="MONDO:0044202" DB="MONDO" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8721" />
                <XRef ID="8721" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="98809" DB="Orphanet" />
              <XRef ID="C1868682" DB="MedGen" />
              <XRef ID="MONDO:0044202" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS128200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5953908" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="15480882|MedGen:C1868682" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003265850" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This premature translational stop signal has been observed in individual(s) with clinical features of PRRT2-related conditions (Invitae). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Leu336*) in the PRRT2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 5 amino acid(s) of the PRRT2 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.29825780del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1868682" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5953908" TraitType="Disease" MappingType="XRef" MappingValue="C1868682" MappingRef="MedGen">
        <MedGen CUI="C1868682" Name="Episodic kinesigenic dyskinesia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

